🇺🇸 FDA

Intelligence · Patent portfolio

Disc Medicine Patents

Full USPTO pharma patent portfolio for Disc Medicine — grant dates, expiration, and drug cross-links.

Patents
706
Expiring ≤24m
26

Quick answer

Disc Medicine has 706 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 26 expire within 24 months — use filters for patent-cliff planning.

Page 4 of 15

  1. US 11345678

    Benzopyrazole compound used as RHO kinase inhibitor

    Expires Mon May 26 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 11345694

    Antibacterial compounds

    Expires Mon May 26 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 11344618

    HIV envelope glycoprotein immunogens

    Expires Mon May 26 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 11345705

    Substituted pyrazolo[1,5-a]pyrimidines as apelin receptor agonists

    Expires Mon May 26 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 11332462

    Heteroaryl compounds and methods of use thereof

    Expires Mon May 12 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 11325907

    Crystal form of 1H-imidazo[4,5-b]pyridine-2(3H)-one compound and preparation process therefor

    Expires Mon May 05 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 11319290

    Substituted 3-dialkylaminomethyl-piperidin-4-yl-benzamides and methods of making and using same

    Expires Mon Apr 28 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 11319330

    Tricyclic furan-substituted piperidinedione compound

    Expires Mon Apr 28 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 11311517

    Combination of small molecule CD-47 inhibitors with other anti-cancer agents

    Expires Mon Apr 21 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 11311560

    Cyclic plasmenylethanolamines

    Expires Mon Apr 21 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 11298530

    Synergistic therapies for intervertebral disc degeneration

    Expires Mon Apr 07 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 11299475

    Prostacyclin receptor agonist

    Expires Mon Apr 07 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 11299482

    Salt and crystal form of modified andrographolide compound and preparation method thereof

    Expires Mon Apr 07 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 11285184

    Cannabidiol alkaline composition

    Expires Mon Mar 24 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 11286352

    Process for preparation of beads for imaging

    Expires Mon Mar 24 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 11279933

    Antisense oligonucleotides for the treatment of leber congenital amaurosis

    Expires Mon Mar 17 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 11274123

    1,2,4-oxadiazole compounds as inhibitors of CD47 signalling

    Expires Mon Mar 10 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 11261164

    Small molecule agonists of neurotensin receptor 1

    Expires Mon Feb 24 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 11254666

    Compound as GLS1 inhibitor

    Expires Mon Feb 17 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 11246947

    Recombinant AAV-crumbs homologue composition and methods for treating LCA-8 and progressive RP

    Expires Mon Feb 10 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 11246859

    Methods and compositions for treating non-ERK MAPK pathway inhibitor-resistant cancers

    Expires Mon Feb 10 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 11236080

    Protein kinase inhibitors

    Expires Mon Jan 27 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. US 11230544

    Substituted 1,3,4-thiadiazoles as GLS1 inhibitors

    Expires Mon Jan 20 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. US 11230549

    Quinolino-pyrrolidin-2-one derivative and application thereof

    Expires Mon Jan 20 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. US 11229636

    Substituted tetrahydroquinolinone compounds as ROR gamma modulators

    Expires Mon Jan 20 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  26. US 11220486

    Inhibitors of low molecular weight protein tyrosine phosphatase and uses thereof

    Expires Mon Jan 06 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  27. US 11208413

    Pyrimidopyrimidinones useful as wee-1 kinase inhibitors

    Expires Mon Dec 23 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  28. US 11207379

    Peptides with anti-cancer activity

    Expires Mon Dec 23 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  29. US 11206005

    Compositions of influenza hemagglutinin with heterologous epitopes and/or altered maturation cleavage sites and methods of use thereof

    Expires Mon Dec 16 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  30. US 11198685

    Substituted ureas and methods of making and using same

    Expires Mon Dec 09 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  31. US 11198686

    Crystal form and salt form of pyridone compound and preparation method therefor

    Expires Mon Dec 09 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  32. US 11192885

    1-heterocyclyl isochromanyl compounds and analogs for treating CNS disorders

    Expires Mon Dec 02 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  33. US 11192886

    S1P1 agonist and application thereof

    Expires Mon Dec 02 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  34. US 11185551

    Peripherally-restricted dual-acting kappa and delta opioid agonist for analgesia in pain states involving the inflammatory response

    Expires Mon Nov 25 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  35. US 11185600

    Contrast agent and its use for imaging

    Expires Mon Nov 25 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  36. US 11186576

    Pyrazolo[1,5-A][1,3,5]triazine and pyrazolo[1,5-A]pyrimidine derivatives as CDK inhibitors

    Expires Mon Nov 25 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  37. US 11179370

    Cannabinoid receptor antagonists/inverse agonists useful for treating disease conditions, including metabolic disorders and cancers

    Expires Mon Nov 18 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  38. US 11174232

    Substituted heterocyclyl derivatives as CDK inhibitors

    Expires Mon Nov 11 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  39. US 11168305

    Methods for the treatment of degenerative disc disease

    Expires Mon Nov 04 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  40. US 11155523

    Biphenyl compound as CCR2/CCR5 receptor antagonist

    Expires Mon Oct 21 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  41. US 11155525

    Azole derivatives as apelin receptor agonist

    Expires Mon Oct 21 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  42. US 11147801

    Methods of use for trisubstituted benzotriazole derivatives as dihydroorotate oxygenase inhibitors

    Expires Mon Oct 14 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  43. US 11135225

    Cancer treatments using combinations of CDK and ERK inhibitors

    Expires Mon Sep 30 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  44. US 11136315

    CXCR2 antagonist

    Expires Mon Sep 30 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  45. US 11130746

    Therapeutic compounds

    Expires Mon Sep 23 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  46. US 11117899

    [1,2,4]triazolo[1,5-c]pyrimidine derivative as A2A receptor inhibitor

    Expires Mon Sep 09 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  47. US 11111238

    Coumarin derivatives, processes for their preparation and uses thereof for the treatment of cancer

    Expires Mon Sep 02 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  48. US 11110134

    Direct-fed microbials

    Expires Mon Sep 02 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many patents does Disc Medicine have?

706 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do Disc Medicine patents expire?

26 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.

Where does this data come from?

USPTO PatentsView bulk data filtered to pharmaceutical CPC classes (A61K, A61P), cross-linked to NovaPharmaNews company and drug profiles. See our data sources page for methodology.

Data attribution: Data sources · Patent directory

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.